Cross-reactive phage-displayed mimotopes lead to the discovery of mimicry between HSV-1 and a brain-specific protein

被引:15
作者
Cortese, I
Capone, S
Luchetti, S
Cortese, R
Nicosia, A
机构
[1] Ist Ric Biol Mol P Angeletti, I-00040 Pomezia, Italy
[2] Univ Roma Tor Vergata, Neurol Clin, Rome, Italy
[3] IRCSS, Clin S Lucia, I-00179 Rome, Italy
关键词
multiple sclerosis; CSF; herpes simplex virus; autoantigen; phage library; mimotope;
D O I
10.1016/S0165-5728(00)00398-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We previously reported the selection of several families of phage-displayed peptide mimics (mimotopes) recognized by oligoclonal immunoglobulins present in the CSF of multiple sclerosis (MS) patients. To search for the natural antigens recognized by these antibodies, anti-sera were raised against one of the mimotopes and used as a probe in ELISA. Western blotting and immunoprecipitation experiments. Anti-mimotope IgG were found to cross-react with an epitope shared by a brain-specific factor conserved from rodents to humans, and the surface glycoprotein gB of HSV-I. These findings support the hypothesis that common viral infections are the triggering agents of self-reactive CSF antibodies, whose role in MS still remains to be elucidated. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:119 / 128
页数:10
相关论文
共 38 条
[21]  
Mecchia M, 1996, J IMMUNOL, V157, P3727
[22]  
MEOLA A, 1995, J IMMUNOL, V154, P3162
[23]  
MOUTHON L, 1995, J IMMUNOL, V154, P5769
[24]   APPLICATION OF THE CONTINUOUS-FLOW POLYAMIDE METHOD TO THE SOLID-PHASE SYNTHESIS OF A MULTIPLE ANTIGEN PEPTIDE (MAP) BASED ON THE SEQUENCE OF A MALARIA EPITOPE [J].
PESSI, A ;
BIANCHI, E ;
BONELLI, F ;
CHIAPPINELLI, L .
JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1990, (01) :8-9
[25]   NEW DIAGNOSTIC-CRITERIA FOR MULTIPLE-SCLEROSIS - GUIDELINES FOR RESEARCH PROTOCOLS [J].
POSER, CM ;
PATY, DW ;
SCHEINBERG, L ;
MCDONALD, WI ;
DAVIS, FA ;
EBERS, GC ;
JOHNSON, KP ;
SIBLEY, WA ;
SILBERBERG, DH ;
TOURTELLOTTE, WW .
ANNALS OF NEUROLOGY, 1983, 13 (03) :227-231
[26]  
Prezzi C, 1996, J IMMUNOL, V156, P4504
[27]  
Raine CS, 1999, ANN NEUROL, V46, P144, DOI 10.1002/1531-8249(199908)46:2<144::AID-ANA3>3.0.CO
[28]  
2-K
[29]  
Scala G, 1999, J IMMUNOL, V162, P6155
[30]  
Smith G P, 1991, Curr Opin Biotechnol, V2, P668, DOI 10.1016/0958-1669(91)90032-Z